Human Mesenchymal Stem Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia in Murine Allogeneic Bone Marrow Transplantation
Jeffery J. Auletta(Nationwide Children's Hospital), Kenneth R. Cooke(Johns Hopkins University), Luis A. Solchaga(Case Western Reserve University), Leland Metheny(Cancer Institute (WIA)), Rocio Guardia-Wolff(Case Western Reserve University), Matthew D. Keller(Case Western Reserve University), Saada Eid(Case Western Reserve University), Zhenghong Lee(Case Western Reserve University)
Cited by 1
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
A biomarker panel for acute graft-versus-host disease
|Blood|2008|404
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
|Journal of Infection|2021|248